PubMed Health⌕ Search

PubMed · 16405133

Recommended effect size statistics for repeated measures designs.

Abstract

Investigators, who are increasingly implored to present and discuss effect size statistics, might comply more often if they understood more clearly what is required. When investigators wish to report effect sizes derived from analyses of variance that include repeated measures, past advice has been problematic. Only recently has a generally useful effect size statistic been proposed for such designs: generalized eta squared (eta2G; Olejnik & Algina, 2003). Here, we present this method, explain that eta2G preferred to eta squared and partial eta squared because it provides comparability across between-subjects and within-subjects designs, show that it can easily be computed from information provided by standard statistical packages, and recommend that investigators provide it routinely in their research reports when appropriate.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Roger Bakeman. 2005. Recommended effect size statistics for repeated measures designs.. https://doi.org/10.3758/bf03192707

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Value of high-cost cancer care: a behavioral science perspective.

Concerns about the high costs of cancer care have led to a renewed interest in understanding how patients value the outcomes of care. Psychologists, economists, and others have highlighted some of the ways in which patients and caregivers perceive and make treatment decisions. Prospect theory is the predominant framework for understanding decisions made in situations where the outcomes of each choice are uncertain. Prospect theory assumes that a patient values the outcomes of care not in absolute terms, such as years of life saved, but as deviations from the patient's point of reference. This article discusses some of the implications of this notion, along with discussing differences among people in their reference points. These and other considerations from the psychology of decision making help to clarify why some patients might be inclined to seek expensive or risky treatments in the hopes of achieving benefits that others might consider not worthwhile. An appreciation of these psychological issues might improve the quality of debates concerning the rising costs of cancer care.

Behavioral Sciences↗